Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial. [electronic resource]
Producer: 19941123Description: 42-8 p. digitalISSN:- 1170-7690
- Adolescent
- Adult
- Bone Marrow Transplantation -- economics
- Double-Blind Method
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- economics
- Health Care Costs
- Hodgkin Disease -- therapy
- Humans
- Insurance Claim Review
- Lymphoma, Non-Hodgkin -- therapy
- Male
- Middle Aged
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- therapy
- Retrospective Studies
- Transplantation, Autologous -- economics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.